GlassScriptPhysician profile
Annette Wilmott
NPI 1982011250
$959.19
in general payments reported to CMS, 2019-2025
17 companies · $319 in 2025
The $319 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $12.31 · 2021: $98.67 · 2022: $54.51 · 2023: $113 · 2024: $230 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $162.62 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Cranial Technologies, INC | $113.42 | 2019-2025 | Doc Band |
| Alk-Abello, INC | $104.38 | 2024-2025 | Grastek, Odactra, Ragwitek |
| Cumberland Pharmaceuticals, INC. | $79.81 | 2024-2025 | Kristalose |
| Tris Pharma INC | $71.65 | 2021-2024 | Dyanavel Xr |
| Kaleo, INC. | $65.06 | 2019-2022 | |
| Corium, LLC | $63.72 | 2024-2025 | Azstarys |
| Pfizer INC. | $62.11 | 2019-2024 | |
| Ars Pharmaceuticals Operations, INC. | $34.48 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $32.52 | 2025 | Bexsero |
| Collegium Pharmaceutical, INC. | $32.24 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $29.93 | 2019-2021 | |
| Neos Therapeutics, LP | $29.86 | 2024-2025 | Cotempla Xr-Odt |
| Supernus Pharmaceuticals, INC. | $29.34 | 2021 | |
| Seqirus USA INC | $19.00 | 2024 | Flucelvax |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $15.38 | 2023 | Flumist Quadrivalent |
| Vertical Pharmaceuticals, LLC | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annette Wilmott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.